Chakrapani Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 5.28%
- Profit Growth -77.64%
- Ebitda -74.23%
- Net Worth 8.15%
- Total Assets 0.43%
About Chakrapani Ayurveda
Chakrapani Ayurveda Private Limited (CAPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2008 and has a history of 16 years and three months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jay Kotecha and Atul Kotecha serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2008PTC027720
-
Company No.
027720
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Nov 2008
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
What products or services does Chakrapani Ayurveda Private Limited offer?
Chakrapani Ayurveda Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pain Balm & Ointments, Guggul, Herbs,Sticks and Roots, Ayurvedic Indian Herbs, Ayurvedic Tablets, Herbal Oil, Herbal Medicinal Oil, Nutraceuticals.
Who are the key members and board of directors at Chakrapani Ayurveda?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Kotecha
|
Director | 28-Dec-2017 | Current |
|
Atul Kotecha
|
Director | 11-Nov-2008 | Current |
Financial Performance of Chakrapani Ayurveda.
Chakrapani Ayurveda Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 5.28% increase. The company also saw a substantial fall in profitability, with a 77.64% decrease in profit. The company's net worth moved up by a moderate rise of 8.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chakrapani Ayurveda?
In 2017, Chakrapani Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chakrapani Ayurveda?
Unlock and access historical data on people associated with Chakrapani Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chakrapani Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chakrapani Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
